EUVIMEDEUVIMED entdecken
Crossref

Extracellular Matrix-Derived Angiogenic Factor(s) Inhibit Endothelial Cell Proliferation, Enhance Differentiation, and Stimulate Angiogenesis in vivo

N Akhta, S Carlso, A Pesarini, N Ambulos, A Passaniti

Endothelium · 2001

DOI: 10.1080/10623320109051567 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endothelium, 2001. Verfasst von N Akhta und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Pathology, University of Maryland School of Medicine and Greenebaum Cancer Center, Baltimore 21201, USA. apass001@umaryland.edu. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To isolate matrix molecules with angiogenic activity, tumor extracellular matrix (ECM) fractions from the basement membrane preparation Matrigel were analyzed for effects on endothelial cell (EC) proliferation, differentiation, and vessel formation in vivo. Inhibition of human and bovine EC DNA synthesis was evident upon treatment with several soluble Matrigel fractions including conditioned media (MGCM). After size fractionation of MGCM, EC growth arrest was activated by factor(s) smaller than 3,000 daltons (3KF). Bovine EC differentiation (tube formation) was promoted by both MGCM and 3KF fractions in two different models using matrigel or collagen gels to stimulate tube formation. The 3KF factor(s) stimulated angiogenesis when implanted in the cornea or subcutaneously in mice. FGF-induced angiogenesis and blood flow were increased in the presence of 3KF factor(s), an effect that was inhibited by the anti-angiogenic molecule endostatin. Further characterization of the low molecular weight 3KF samples by RP-HPLC revealed several fractions exhibiting EC growth arrest activity. These results suggest that the ability of ECM preparations to induce EC growth arrest and tube formation may reside, at least partially, in previously undetected low molecular weight molecules. Characterization of these ECM-associated inhibitors may lead to the development of novel anti-angiogenic and anti-tumor compounds.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiogenesis Inducing AgentsAnimalsCell DifferentiationCell DivisionCorneaCulture Media, ConditionedEndothelium, VascularExtracellular MatrixGrowth SubstancesHumansMiceNeovascularization, PhysiologicUmbilical VeinsWounds and Injuries

Substanzen

Angiogenesis Inducing AgentsCulture Media, ConditionedGrowth Substances

Autor:innen und Institutionen

  • The Department of Pathology, University of Maryland School of Medicine and Greenebaum Cancer Center, Baltimore 21201, USA. apass001@umaryland.edu

Zitieren

APA

Akhta, N., Carlso, S., Pesarini, A., Ambulos, N., & Passaniti, A. (2001). Extracellular Matrix-Derived Angiogenic Factor(s) Inhibit Endothelial Cell Proliferation, Enhance Differentiation, and Stimulate Angiogenesis in vivo. Endothelium. https://doi.org/10.1080/10623320109051567

Vancouver

Akhta N, Carlso S, Pesarini A, Ambulos N, Passaniti A. Extracellular Matrix-Derived Angiogenic Factor(s) Inhibit Endothelial Cell Proliferation, Enhance Differentiation, and Stimulate Angiogenesis in vivo. Endothelium. 2001. doi:10.1080/10623320109051567

BibTeX
@article{Akhta2001,
  author = {Akhta, N and Carlso, S and Pesarini, A and Ambulos, N and Passaniti, A},
  title = {Extracellular Matrix-Derived Angiogenic Factor(s) Inhibit Endothelial Cell Proliferation, Enhance Differentiation, and Stimulate Angiogenesis in vivo},
  journal = {Endothelium},
  year = {2001},
  doi = {10.1080/10623320109051567}
}
Kostenlos starten →